(Q73181340)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Hyperuricemia and renal insufficiency associated with malignant disease: urate oxidase as an efficient therapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Wolf G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hegewisch-Becker S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hossfeld DK

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Stahl RA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

E20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

Tumour lysis syndrome, case report and review of the literature

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

The spectrum of acute renal failure in tumour lysis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Editorial: The kidney and uric acid excretion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Pathogenesis and therapy of interstitial nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Urate oxidase in hyperuricemic heart transplant recipients treated with azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Intravascular-catheter-related infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Advances in the management of malignancy-associated hyperuricaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Letter: Treatment of malignant haemopathies and urate oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Hypouricaemic effect of polyethyleneglycol modified urate oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970062-4

7 January 2021

10.1016/S0272-6386(99)70062-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10561160%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference